Comment on: 'Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients'

Esmeralda Garza-Santiago, Alejandro Ortiz-Hernández, Ashuin Kammar-Garciá, Javier Mancilla-Galindo*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)1277-1281
Number of pages5
JournalFuture Microbiology
Volume17
Issue number16
DOIs
Publication statusPublished - 1 Nov 2022
Externally publishedYes

Keywords

  • coronavirus
  • COVID-19
  • ivermectin
  • research design

Cite this